S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.57 (+0.33%)
AAPL   174.14 (-0.23%)
MSFT   290.09 (-0.42%)
META   174.67 (-0.10%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.47 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
T   18.40 (-0.11%)
MU   63.08 (+2.37%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   18.76 (-12.17%)
PYPL   99.85 (+0.43%)
PFE   48.60 (-1.36%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.57 (+0.33%)
AAPL   174.14 (-0.23%)
MSFT   290.09 (-0.42%)
META   174.67 (-0.10%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.47 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
T   18.40 (-0.11%)
MU   63.08 (+2.37%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   18.76 (-12.17%)
PYPL   99.85 (+0.43%)
PFE   48.60 (-1.36%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.57 (+0.33%)
AAPL   174.14 (-0.23%)
MSFT   290.09 (-0.42%)
META   174.67 (-0.10%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.47 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
T   18.40 (-0.11%)
MU   63.08 (+2.37%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   18.76 (-12.17%)
PYPL   99.85 (+0.43%)
PFE   48.60 (-1.36%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.57 (+0.33%)
AAPL   174.14 (-0.23%)
MSFT   290.09 (-0.42%)
META   174.67 (-0.10%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.47 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
T   18.40 (-0.11%)
MU   63.08 (+2.37%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   18.76 (-12.17%)
PYPL   99.85 (+0.43%)
PFE   48.60 (-1.36%)
NFLX   244.83 (+1.53%)
NYSE:CLB

Core Laboratories - CLB Stock Forecast, Price & News

$16.98
+0.65 (+3.98%)
(As of 08/18/2022 04:34 PM ET)
Add
Compare
Today's Range
$16.60
$17.06
50-Day Range
$15.40
$27.15
52-Week Range
$15.21
$35.83
Volume
184,318 shs
Average Volume
488,806 shs
Market Capitalization
$786.60 million
P/E Ratio
89.37
Dividend Yield
0.24%
Price Target
$23.33

Core Laboratories MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
38.2% Upside
$23.33 Price Target
Short Interest
Bearish
9.99% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.95mentions of Core Laboratories in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
75.93%
From $0.54 to $0.95 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.62 out of 5 stars

Oils/Energy Sector

54th out of 254 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

8th out of 23 stocks

CLB stock logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Core Laboratories Trading Up 1.1 %

Shares of NYSE:CLB opened at $16.33 on Thursday. The stock has a market capitalization of $756.49 million, a PE ratio of 85.95, a P/E/G ratio of 0.76 and a beta of 2.59. Core Laboratories has a 1 year low of $15.21 and a 1 year high of $35.83. The firm has a fifty day moving average price of $18.72 and a 200 day moving average price of $25.10. The company has a current ratio of 2.08, a quick ratio of 1.53 and a debt-to-equity ratio of 1.08.

Core Laboratories (NYSE:CLB - Get Rating) last released its quarterly earnings results on Wednesday, July 27th. The oil and gas company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.14 by ($0.02). Core Laboratories had a net margin of 1.82% and a return on equity of 16.12%. The firm had revenue of $120.90 million for the quarter, compared to the consensus estimate of $121.35 million. During the same quarter last year, the company earned $0.18 earnings per share. The firm's revenue was up 1.8% on a year-over-year basis. Analysts expect that Core Laboratories will post 0.54 EPS for the current fiscal year.

Core Laboratories Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 29th. Shareholders of record on Monday, August 8th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend is Friday, August 5th. Core Laboratories's dividend payout ratio (DPR) is 21.05%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Stifel Nicolaus dropped their price target on shares of Core Laboratories from $26.00 to $20.00 in a research note on Tuesday, July 26th. StockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 11th. Finally, Morgan Stanley decreased their price objective on shares of Core Laboratories from $22.00 to $20.00 and set an "equal weight" rating for the company in a report on Monday, August 1st.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Core Laboratories: A Speculative Buy At Present Levels
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
SLB or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories goes ex-dividend tomorrow
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Why Energy Stocks Dropped on Monday
Core Laboratories (CLB) Q2 Earnings Match Estimates
Why Shares in Core Labs Fell Today
Why Core Labs Stock Dived by More Than 10% Today
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Company Calendar

Ex-Dividend for 5/31 Dividend
5/06/2022
Dividend Payable
5/31/2022
Last Earnings
7/27/2022
Ex-Dividend for 8/29 Dividend
8/05/2022
Today
8/18/2022
Dividend Payable
8/29/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,700
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$23.33
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+37.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$19.73 million
Pretax Margin
4.48%

Debt

Sales & Book Value

Annual Sales
$470.25 million
Cash Flow
$1.18 per share
Book Value
$3.75 per share

Miscellaneous

Free Float
46,130,000
Market Cap
$786.60 million
Optionable
Optionable
Beta
2.59

Social Links


Key Executives

  • Mr. Lawrence V. Bruno (Age 62)
    Chairman, CEO, Pres & COO
    Comp: $1.61M
  • Mr. Christopher Scott Hill (Age 52)
    Sr. VP & CFO
    Comp: $702.65k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 54)
    Sr. VP of Corp. Devel. & Investor Relations
    Comp: $612.71k
  • Mr. Mark Damian Tattoli (Age 50)
    Sr. VP, Sec. & Gen. Counsel
    Comp: $948.9k
  • Mr. Kevin G. Daniels (Age 58)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 67)
    Managing Director
  • J. Donald Dumas Jr.
    Sr. VP of Production Enhancement & Bus. Devel.













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "sell" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2022?

3 Wall Street research analysts have issued 12 month price objectives for Core Laboratories' shares. Their CLB share price forecasts range from $20.00 to $32.00. On average, they anticipate the company's share price to reach $23.33 in the next year. This suggests a possible upside of 42.8% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2022?

Core Laboratories' stock was trading at $22.31 at the beginning of 2022. Since then, CLB shares have decreased by 26.8% and is now trading at $16.33.
View the best growth stocks for 2022 here
.

Are investors shorting Core Laboratories?

Core Laboratories saw a decline in short interest in July. As of July 31st, there was short interest totaling 4,590,000 shares, a decline of 11.2% from the July 15th total of 5,170,000 shares. Based on an average daily volume of 459,400 shares, the days-to-cover ratio is currently 10.0 days. Approximately 10.0% of the company's stock are sold short.
View Core Laboratories' Short Interest
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our CLB earnings forecast
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Wednesday, July, 27th. The oil and gas company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.14 by $0.02. The oil and gas company had revenue of $120.90 million for the quarter, compared to the consensus estimate of $121.35 million. Core Laboratories had a net margin of 1.82% and a trailing twelve-month return on equity of 16.12%. Core Laboratories's revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.18 EPS.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 29th. Shareholders of record on Monday, August 8th will be paid a dividend of $0.01 per share on Monday, August 29th. This represents a $0.04 annualized dividend and a yield of 0.24%. The ex-dividend date is Friday, August 5th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.25%. The dividend payout ratio is 21.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.21% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $0.13-$0.18 for the period, compared to the consensus estimate of $0.20. The company issued revenue guidance of $123.00 million-$129.00 million, compared to the consensus revenue estimate of $125.12 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (4.30%), Van ECK Associates Corp (4.14%), State Street Corp (2.80%), Douglas Lane & Associates LLC (1.19%), Congress Asset Management Co. MA (1.10%) and Sei Investments Co. (1.04%). Insiders that own company stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $16.33.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $756.57 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.19 on an earnings per share basis.

How many employees does Core Laboratories have?

The company employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.